Loading…
Spatial analysis of the occurrence of protected butterflies in six European biogeographic regions as a tool for the environmental risk assessment of Bt maize
In the environmental risk assessment (ERA) of genetically modified plants (GMP), the consideration of the different environments where genetically modified plants (GMP) will be commercially grown (the receiving environments) plays a crucial role. In addition, relevant protection goals which may be a...
Saved in:
Published in: | BioRisk 2018-02, Vol.13 (154), p.31-52 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In the environmental risk assessment (ERA) of genetically modified plants (GMP), the consideration of the different environments where genetically modified plants (GMP) will be commercially grown (the receiving environments) plays a crucial role. In addition, relevant protection goals which may be adversely affected by the GMP have to be considered during the ERA. Using a literature- and GIS-based approach, distribution data of protected lepidopteran species listed in Council Directive 92/43/EEC and of maize cultivation was used in order to evaluate potential spatial overlaps between GM maize and protected non-target Lepidoptera in different biogeographical regions (BGR) of the EU. Each BGR has its peculiarity regarding maize cultivation and the distribution of protected butterflies. The lepidopteran fauna of the Pannonian BGR is particularly sensitive due to large maize cultivation shares and wide distribution of protected butterflies within this BGR. For the BGRs evaluated potential, spatial exposures of protected butterflies to GM maize cannot be excluded. This study shows that the suggested approach is a useful tool for the consideration of EU-wide protected species in different receiving environments during the problem formulation of the ERA of GMPs. |
---|---|
ISSN: | 1313-2644 1313-2652 |
DOI: | 10.3897/biorisk.13.20688 |